
Cytokinetics and Novartis’ starcrossed tale
If you are interested in staying up to date on the latest developments in the biotech industry, you can sign up for the STAT biotech newsletter in your inbox. This week’s newsletter includes topics such as the aftermath of the JPM conference, FDA review of GLP-1 drugs, Novartis’ decision not to acquire Cytokinetics, and a…